Fukudo Masahide 福土将秀

… Alternative Names

FUKUDO Masahide 福土将秀

Less

Researcher Number	60437233
Affiliation (Current)	2022: 札幌医科大学, 医学部, 教授 2022: 京都大学, 医学研究科, 助教
Affiliation (based on the past Project Information) *help	2020 – 2021: 札幌医科大学, 医学部, 教授 2014 – 2019: 旭川医科大学, 医学部, 准教授 2014: 京都大学, 医学研究科, 助教 2011 – 2014: 京都大学, 医学(系)研究科(研究院), 助教 2012: 京都大学, 医学研究科, 助教 … More 2012: 京都大学, 医学系研究科, 助教 2011: 京都大学, 大学院・医学研究科, 助教 2008 – 2010: Kyoto University, 医学研究科, 助教 2007: 京都大学, 医学研究科, 技術職員 2007: Kyoto University, 医学研究科, 技術職員(薬剤師) Less
Review Section/Research Field	Principal Investigator Applied pharmacology / Basic Section 47060:Clinical pharmacy-related Except Principal Investigator Medical pharmacy
Keywords	Principal Investigator 薬物動態 / 個別化投与設計 / 薬効 / 分子標的治療薬 / 副作用 / ゲノム情報 / ミコフェノール酸 / 相互作用 / 医薬品適正使用 / 肝移植 … More / 薬物動熊 / 有効性 / 安全性 / 個別最適投与 / 薬理ゲノム / 個別最適化 / がん分子標的薬 / 代謝物 / 薬剤感受性 / 代謝 / Precision Medicine / 薬物代謝酵素 / トランスポーター / 免疫チェックポイント阻害薬 / 抗薬物抗体 / 最適使用法 / PK/PD / 個別化がん免疫療法 … More Except Principal Investigator 薬剤反応性 / 薬物動態 / 薬学 / 移植・再生医療 / 薬理学 / 免疫抑制剤 / 薬物相互作用 / mTOR阻害剤 / オーダーメイド医療 / 臨床薬物動態学 / 遺伝子 / 脳神経疾患 / 薬物動態学 / 薬力学 / P-糖タンパク質 / 遺伝学 / 母集団解析 / 癌 / 分子標的抗がん剤 / がん / パーキンソン病 / L-dopa / ウエアリング・オフ / COMT遺伝子多型 / エンタカポン / L-ドパ / 遺伝子多型 / トランスポータ / パーキンソン病治療薬 / オキシカム系非ステロイド性抗炎症薬 / メロキシカム / 新規進行抑制薬 / 神経細胞死抑制 / パーキンソン病進行抑制薬 / オキシカム系NSAIDs / meloxicam / ドラッグリプロファイリング / Akt / 細胞生存シグナル / 神経細胞死抑制薬 / オキシカム系NSAIDｓ / TrkA / mTOR Less

免疫チェックポイント阻害薬のPK/PD解析と抗薬物抗体評価に基づく最適使用法開発Principal Investigator
- Principal Investigator
  
  福土将秀
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Sapporo Medical University
Personalized dosing of targeted anticancer drugs by elucidating mechanisms underlying the variability in pharmacokinetics and pharmacodynamicsPrincipal Investigator
- Principal Investigator
  
  Fukudo Masahide
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Asahikawa Medical College
Development of the antiparkinsonian drug with novel mechanism by drug-reprofiling.
- Principal Investigator
  
  TASAKI YOSHIKAZU
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Asahikawa Medical College
Individualized L-dopa therapy in patients with Parkinson's disease
- Principal Investigator
  
  MATSUBARA Kazuo
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kyoto University
Individualized molecular targeted therapy based on pharmacogenomics and pharmacokinetic optimizationPrincipal Investigator
- Principal Investigator
  
  FUKUDO Masahide
- Project Period (FY)
  2011 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Applied pharmacology
- Research Institution
  Kyoto University
Construction of administration algorithm of novel oral molecular-targeted anti-cancer drugs based on the clarificationof interindividual differences of pharmacokinetics and pharmacodynamics
- Principal Investigator
  
  TERADA Tomohiro, 寺田智祐
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Shiga University of Medical Science
Population pharmacokinetics and pharmacodynamics and individualized therapy in patients with refractory epilepsy
- Principal Investigator
  
  YANO Ikuko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kyoto University
Development of personalized chemotherapy with novel molecular targeted agents based on pharmacokinetic and pharmacogenomic analysisPrincipal Investigator
- Principal Investigator
  
  FUKUDO Masahide
- Project Period (FY)
  2009 – 2010
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Applied pharmacology
- Research Institution
  Kyoto University
Dosage schedule based on pharmacokinetic and pharmacodynamic interaction of immunosuppressants
- Principal Investigator
  
  YANO Ikuko
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kyoto University
Optimal mycophenolate therapy based on population pharmacokinetic and pharmacodynamic analysis in liver transplant patientsPrincipal Investigator
- Principal Investigator
  
  FUKUDO Masahide
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Applied pharmacology
- Research Institution
  Kyoto University

All 2021 2019 2018 2017 2016 2013 2012 2011 2010 2009 2008 2007 Other

All Journal Article Presentation

[Journal Article] Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients2021
- Author(s)
  Fujii Satoshi、Ibe Yuta、Ishigo Tomoyuki、Inamura Hirotoshi、Kunimoto Yusuke、Fujiya Yoshihiro、Kuronuma Koji、Nakata Hiromasa、Fukudo Masahide、Takahashi Satoshi
- Journal Title
  
  J Infect Chemother.
  
  Volume: 27 Pages: 1051-1057
- DOI
  10.1016/j.jiac.2021.04.013
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07126, KAKENHI-PROJECT-20K08570
[Journal Article] Pharmacokinetics of the oral multikinase inhibitor regorafenib and its association with real‐world treatment outcomes2021
- Author(s)
  Fukudo Masahide、Asai Keiko、Tani Chikayoshi、Miyamoto Masashi、Ando Katsuyoshi、Ueno Nobuhiro
- Journal Title
  
  Investigational New Drugs
  
  Volume: - Pages: 1422-1431
- DOI
  10.1007/s10637-021-01115-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17419, KAKENHI-PROJECT-20K07126
[Journal Article] Potential drug?drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan2021
- Author(s)
  Kunimoto Yusuke、Matamura Ryosuke、Ikeda Hiroshi、Fujii Satoshi、Kimyo Tomoko、Kitagawa Manabu、Nakata Hiromasa、Kobune Masayoshi、Miyamoto Atsushi、Fukudo Masahide
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 7 Pages: 43-43
- DOI
  10.1186/s40780-021-00226-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08871, KAKENHI-PROJECT-20K07126
[Journal Article] Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma2021
- Author(s)
  Fukudo M, Tamaki G, Azumi M, Kakizaki H, Matsumoto S, Tasaki Y
- Journal Title
  
  Invest New Drugs
  
  Volume: 39 Pages: 595-604
- DOI
  10.1007/s10637-020-01023-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07126
[Journal Article] Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer2021
- Author(s)
  Fukudo Masahide、Ishibashi Kei、Kitada Masahiro
- Journal Title
  
  Investigational New Drugs
  
  Volume: 39 Pages: 1707-1715
- DOI
  10.1007/s10637-021-01131-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07126
[Journal Article] Pharmacokinetically guided dosing has the potential to improve real-world outcomes of pazopanib2021
- Author(s)
  Fukudo M, Tamaki G, Azumi M, Shibata H, Tandai S
- Journal Title
  
  Br J Clin Pharmacol
  
  Volume: 87 Pages: 2132-2139
- DOI
  10.1111/bcp.14580
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07126
[Journal Article] Efficacy and Safety of Linaclotide in Elderly Patients2021
- Author(s)
  Ishigo T, Shimotsubo T, Takada R, Nakano K, Fujii S, Kitagawa M, Kimyo T, Nakata H, Fukudo M
- Journal Title
  
  YAKUGAKU ZASSHI
  
  Volume: 141 Issue: 2 Pages: 255-262
- DOI
  10.1248/yakushi.20-00176
- NAID
  130007978821
- ISSN
  0031-6903, 1347-5231
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K07126
[Journal Article] Lymph Node Metastasis From Gastroesophageal Cancer Successfully Treated by Nivolumab: A Case Report of a Young Patient2019
- Author(s)
  Kashima S, Tanabe H, Tanino M, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Moriichi K, Fukudo M, Tasaki Y, Hosokawa M, Mizukami Y, Fujiya M, Okumura T.
- Journal Title
  
  Frontiers in Oncology
  
  Volume: 9 Pages: 1375-1375
- DOI
  10.3389/fonc.2019.01375
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17419, KAKENHI-PROJECT-16K08902, KAKENHI-PROJECT-17K09451, KAKENHI-PROJECT-17K09472, KAKENHI-PROJECT-17K15911
[Journal Article] The influence of Neanderthal alleles on cytotoxic response2018
- Author(s)
  Akhtari FS, Havener TM, Fukudo M, Jack JR, McLeod HL, Wiltshire T, Motsinger-Reif AA
- Journal Title
  
  PeerJ
  
  Volume: 6
- DOI
  10.7717/peerj.5691
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08902
[Journal Article] Pharmacokinetics and pharmacodynamics of once-daily tacrolimus compared with twice-daily tacrolimus in the early stage after living donor liver transplantation2018
- Author(s)
  Iwasaki M, Yano I, Fukatsu S, Hashi S, Yamamoto Y, Sugimoto M, Fukudo M, Masuda S, Nakagawa S, Yonezawa A, Kaido T, Uemoto S, Matsubara K
- Journal Title
  
  Therapeutic Drug Monitoring
  
  Volume: 印刷中
- NAID
  120006559313
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08902
[Journal Article] Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma2016
- Author(s)
  Tanaka A, Yano I, Shinsako K, Sato E, Fukudo M, Masuda S, Yamasaki T, Kamba T, Ogawa O, Matsubara K
- Journal Title
  
  Ther Drug Monit
  
  Volume: 38 Pages: 663-669
- DOI
  10.1097/ftd.0000000000000344
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16K08400, KAKENHI-PROJECT-16K08902
[Journal Article] Population Pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer2013
- Author(s)
  Fukudo M, Ikemi Y, Togashi Y, Masago K, Kim YH, Mio T, Terada T, Teramukai S, Mishima M, Inui K, Katsura T.
- Journal Title
  
  Clin. Pharmacokinet.
  
  Volume: 52 Pages: 593-609
- DOI
  10.1007/s40262-013-0058-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390138, KAKENHI-PROJECT-23790597, KAKENHI-PROJECT-25460187, KAKENHI-PROJECT-25670074
[Journal Article] Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.2013
- Author(s)
  Masahide Fukudo
- Journal Title
  
  Clin. Pharmacokinet.
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Significance of trough monitoring for tacrolimus blood concentration and calcineurin2012
- Author(s)
  Yano I, Masuda S, Egawa H, Sugimoto Y, Fukudo M, Yoshida Y, Hashi S, Yoshizawa A, Ogura Y, Ogawa K, Mori A, Kaido T, Uemoto S, Inui K
- Journal Title
  
  European Journal of Clinical Pharmacolology
  
  Volume: 68(3) Pages: 259-266
- DOI
  10.1007/s00228-011-1129-x
- NAID
  120003988188
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590156
[Journal Article] Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer2012
- Author(s)
  Yosuke Togashi
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 70 Pages: 399-405
- DOI
  10.1007/s00280-012-1929-4
- NAID
  120004874020
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390138, KAKENHI-PROJECT-23790597
[Journal Article] Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2)on sunitinib pharmacokinetics2012
- Author(s)
  Mizuno, T., Fukudo, M., Terada, T., Kamba, T.
- Journal Title
  
  Drug Metab. Pharmacokinet
  
  Volume: 27(6) Pages: 631-639
- NAID
  130004933515
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Impact of Genetic Variation in Breast Cancer Resistance Protein (<i>BCRP</i>/<i>ABCG2</i>) on Sunitinib Pharmacokinetics2012
- Author(s)
  Tomoyuki Mizuno
- Journal Title
  
  DMPK
  
  Volume: 27 Issue: 6 Pages: 631-639
- DOI
  10.2133/dmpk.dmpk-12-rg-026
  10.2133/dmpk.DMPK-12-RG-026
- NAID
  130004933515
- ISSN
  1347-4367, 1880-0920
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390138, KAKENHI-PROJECT-23790597
[Journal Article] Plasma and pleural fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small-cell lung cancer with pleural effusion.2011
- Author(s)
  Masago, K., Togashi, Y., Fukudo, M., Terada, T.
- Journal Title
  
  Clin Lung Cancer
  
  Volume: 12(5) Pages: 307-312
- DOI
  10.1016/j.cllc.2011.06.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029, KAKENHI-PROJECT-23790597
[Journal Article] Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation.2011
- Author(s)
  Togashi Y, et al
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 68 Pages: 1089-1092
- DOI
  10.1007/s00280-011-1691-z
- NAID
  120003534363
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390138, KAKENHI-PROJECT-23790597
[Journal Article] A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.2010
- Author(s)
  Fukudo, M., et al.
- Journal Title
  
  Drug Metab.Pharmacokinet.
  
  Volume: 25 Pages: 411-417
- NAID
  10027583568
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590156
[Journal Article] Good clinical response to erlotinib in a non-small cell lung cancer patient harboring multiple brain metastases and a double active somatic epidermal growth factor gene mutation2010
- Author(s)
  Masago, K., Togashi, Y., Fukudo, M., Terada, T.
- Journal Title
  
  Case Rep. Oncol
  
  Volume: 3(2) Pages: 98-105
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis2010
- Author(s)
  Togashi Y, Masago K, Fukudo M, Terada T, Ikemi Y, Kim YH, Fujita S, Irisa K, Sakamori Y, Mio T, Inui K, Mishima M.
- Journal Title
  
  J Thorac Oncol 5
  
  Pages: 601-605
- Data Source
  KAKENHI-PROJECT-21790520
[Journal Article] ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma2010
- Author(s)
  Mizuno T, Terada T, Kamba T, Fukudo M, Katsura T, Nakamura E, Ogawa O, Inui K.
- Journal Title
  
  Ann Oncol 21
  
  Pages: 1382-1383
- Data Source
  KAKENHI-PROJECT-21790520
[Journal Article] Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis2010
- Author(s)
  Togashi, Y, Masago, K., Fukudo, M., Terada, T.
- Journal Title
  
  J. Thorac. Oncol
  
  Volume: 5(5) Pages: 601-605
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Good clinical response to erlotinib in a non-small cell lung cancer patient harboring multiple brain metastases and a double active somatic epidermal growth factor gene mutation2010
- Author(s)
  Masago K, Togashi Y, Fukudo M, Terada T, Irisa K, Sakamori Y, Fujita S, Kim YH, Mio T, Inui K, Mishima M.
- Journal Title
  
  Case Rep Oncol 3
  
  Pages: 98-105
- Data Source
  KAKENHI-PROJECT-21790520
[Journal Article] ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma2010
- Author(s)
  Mizuno, T., Terada, T., Kamba, T., Fukudo, M.
- Journal Title
  
  Ann.Oncol
  
  Volume: 21(6) Pages: 1382-1383
- DOI
  10.1093/annonc/mdq150
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system etastases of non-small cell lung cancer2010
- Author(s)
  Togashi, Y, Masago, K., Fukudo, M., Terada, T.
- Journal Title
  
  J. Thorac. Oncol
  
  Volume: 5(7) Pages: 950-955
- DOI
  10.1097/jto.0b013e3181e2138b
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Journal Article] Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer2010
- Author(s)
  Togashi Y, Masago K, Fukudo M, Terada T, Fujita S, Irisa K, Sakamori Y, Kim YH, Mio T, Inui K, Mishima M
- Journal Title
  
  J Thorac Oncol 5
  
  Pages: 950-955
- Data Source
  KAKENHI-PROJECT-21790520
[Journal Article] A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection2010
- Author(s)
  Fukudo M, Yano I, Katsura T, Ito N, Yamamoto S, Kamoto T, Ogawa O, Inui K
- Journal Title
  
  Drug Metab Pharmacokinet
  
  Volume: 25(5) Pages: 411-417
- NAID
  10027583568
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590156
[Journal Article] Prospective evaluation of the Bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation2009
- Author(s)
  Fukudo, M., Yano, I., Shinsako, K., Katsura, T., Takada, Y., Uemoto, S., Inui, K.
- Journal Title
  
  J. Clin. Phamacol (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590141
[Journal Article] Population analysis of myelosuppression profiles using routine clinical data after combination cancer chemotherapy2009
- Author(s)
  Fukudo M, Yano I, Shinsako K, Katsura T, Takada Y, Uemoto S, Inui K
- Journal Title
  
  J Pharm Sci
  
  Volume: 49(7) Pages: 4402-4412
- DOI
  10.1002/jps.21731
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590156
[Journal Article] Prospective evaluation of the Bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation2009
- Author(s)
  Fukudo, M.
- Journal Title
  
  J Clin Pharmacol
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790387
[Journal Article] Prospective evaluation of the Bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.2009
- Author(s)
  Fukudo, M., Yano, I., et al.
- Journal Title
  
  J. Clin. Phamacol.
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590141
[Journal Article] Prospective evaluation of the Bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation2009
- Author(s)
  Fukudo, M., Yano, I., Shinsako, K., Katsura, T., Takada, Y., Uemoto, S., Inui, K.
- Journal Title
  
  J. Clin. Pharmacol. (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790387
[Journal Article] Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients2008
- Author(s)
  Fukudo, M., Yano, I., Yoshimura, A., Masuda, S., Uesugi, M., Hosohata, K., Katsura, T., Ogura, Y., Oike, F., Takada, Y., Uemoto, S., Inui, K
- Journal Title
  
  Pharmacogenet. Genomics 18(5)
  
  Pages: 413-423
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590141
[Journal Article] Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients2008
- Author(s)
  Fukudo, M., Yano, I., Yoshimura, A., Masuda, S., Uesugi, M., Hosohata, K., Katsura, T., Ogura, Y., Oike, F., Takada, Y., Uemoto, S., Inui, K.
- Journal Title
  
  Pharmacogenet. Genomics 18
  
  Pages: 413-423
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790387
[Journal Article] カルシニューリン阻害剤の体内動態と薬効の速度論的解析に基づく個別化投与設計法2008
- Author(s)
  矢野育子、福土将秀、増田智先、小倉靖弘、尾池文隆、田中紘一、乾賢一
- Journal Title
  
  臨床薬理の進歩2008 29
  
  Pages: 113-119
- Data Source
  KAKENHI-PROJECT-19590141
[Journal Article] Impact of intestinal MDR1 and CYP3A5 on the oral clearance of tacrolimus in adult living-donor liver transplant patients.2008
- Author(s)
  Fukudo, M., Yano, I., et. al.
- Journal Title
  
  Pharmacogenet. Genomics (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590141
[Journal Article] Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients2008
- Author(s)
  Fukudo, M.
- Journal Title
  
  Pharmacogenet. Genomics 18
  
  Pages: 413-423
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19790387
[Journal Article] Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer
- Author(s)
  Fukudo, M., Ikemi, Y., Togashi, Y., Masago, K., Kim, Y.H., Mio, T., Terada, T., Teramukai, S.
- Journal Title
  
  Clin. Pharmacokinet
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390029
[Presentation] がん領域における新規TDM対象薬剤の拡大に向けて2021
- Author(s)
  福土　将秀
- Organizer
  第31回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-20K07126
[Presentation] 抗PD-1抗体薬ニボルマブとペムブロリズマブの薬物動態と免疫原性の長期観察研究2021
- Author(s)
  福土　将秀
- Organizer
  第13回JBFシンポジウム
- Data Source
  KAKENHI-PROJECT-20K07126
[Presentation] Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti-PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice2019
- Author(s)
  Fukudo M, Mishima K, Kimura N, et al.
- Organizer
  第55回米国臨床腫瘍学会年会 (ASCO2019)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] 薬物体内動態評価に基づく抗がん剤治療の最適化に向けて2019
- Author(s)
  福土将秀
- Organizer
  第2回日本腫瘍循環器学会学術集会
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] TDMを活用したがん分子標的抗薬の個別化治療戦略 -Start Low and Go Slow-2019
- Author(s)
  福土将秀
- Organizer
  第36回日本TDM学会学術大会
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] ニボルマブ治療終了後イピリムマブ投与によって劇症1型糖尿病を発症した悪性黒色腫患者の一例報告2019
- Author(s)
  小林直貴、福土将秀、寺川央一、佐々木健太、小林友紀、上原治朗、山本明美、三嶋一登、田﨑嘉一
- Organizer
  日本臨床腫瘍薬学会学術大会2019
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] 北海道内におけるニボルマブ廃棄量の実態調査とその解消方策に関する多施設共同研究（NEWHOPE STUDY）―最終報告―2018
- Author(s)
  福土将秀、石川良太、相馬亮太、吉田光一、木村周古、新田悠一朗、小枝正吉、三嶋一登、小野尚志、田﨑嘉一
- Organizer
  第28回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] Regorafenib pharmacokinetics and exposure-toxicity relationship in Japanese cancer patients2018
- Author(s)
  Fukudo M, Kubo Y, Shinden Y, Koeda M, Tani C, Miyamoto M, Asai K, Furukawa H, Ueno N, Okumura T, Tasaki Y
- Organizer
  第16回国際TDM会議 (IATDMCT2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] HILIC-MS/MSを用いたレゴラフェニブと代謝物の同時分析と個別化投与設計に関する研究2017
- Author(s)
  福土将秀、久保靖憲、小枝正吉、谷　誓良、宮本正之、浅井慶子、古川博之、上野伸展、奥村利勝、田﨑嘉一
- Organizer
  第38回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] 抗PD-1抗体薬ニボルマブおよびペムブロリズマブの臨床薬物動態に関する検討2017
- Author(s)
  福土将秀、吉田光一、寺川央一、佐々木高明、大崎能伸、上原治朗、山本明美、玉木　岳、安住　誠、柿崎秀宏、三嶋一登、田﨑嘉一
- Organizer
  第38回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] 分子標的抗がん薬の薬物動態評価に基づく処方設計支援2016
- Author(s)
  福土将秀
- Organizer
  第26回日本医療薬学会年会
- Place of Presentation
  国立京都国際会館（京都市）
- Year and Date
  2016-09-17
- Data Source
  KAKENHI-PROJECT-16K08902
[Presentation] 腎細胞がんおよび肝細胞がん患者におけるソラフェニブの母集団薬物動態解析2012
- Author(s)
  水野知行、福土将秀、寺田智祐、國松佐千子、新迫恵子、津田真弘、波多野悦朗、上本伸二、神波大己、中村英二郎、小川修、妹尾浩、千葉勉、乾賢一、桂敏也
- Organizer
  日本薬剤学会第27年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] PK/PD approaches for optimal molecular targeted cancer therapy2012
- Author(s)
  Terada, T., Mizuno, T., Fukudo, M., Inui, K. and Katsura, T.
- Organizer
  日本薬物動態学会第27回年会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-22390029
[Presentation] スニチニブの体内動態に及ぼすABCB1、ABCG2 阻害の影響2012
- Author(s)
  國松佐千子、水野知行、福土将秀、桂敏也、松原和夫.
- Organizer
  第62回日本薬学会近畿支部総会・大会
- Place of Presentation
  兵庫県西宮
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Role of ABCG2 and ABCB1 in sunitinib pharmacokinetics.2011
- Author(s)
  Mizuno T, Fukudo M, Katsura T.
- Organizer
  26thJSSX Annual Meeting
- Place of Presentation
  Hiroshima
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Population pharmacokinetics and pharmacogenomics of erlotinib: Effect of drug exposure on treatment outcomes in Japanese patients with non-small cell lung cancer2011
- Author(s)
  Fukudo M
- Organizer
  第47回米国臨床腫瘍学会総会（2011 ASCO Annual Meeting）
- Place of Presentation
  マコーミックプレイス（シカゴ市、アメリカ）
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Significance of trough monitoring of tacrolimus blood concentration and calcineurin activity in living-donor liver transplant patients2011
- Author(s)
  Yano I, Masuda S, Egawa H, Sugimoto M, Fukudo M, Yoshida Y, Yasuda Y, Kaido T, Uemoto S, Inui K
- Organizer
  12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology
- Place of Presentation
  Stuttgart,(Germany)
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-21590156
[Presentation] エルロチニブの母集団薬物動態と副作用に関する薬理ゲノム解析2011
- Author(s)
  福土将秀、池見泰明、冨樫庸介、真砂勝泰、金永学、三嶋理晃、桂敏也
- Organizer
  第32回日本臨床薬理学会年会
- Place of Presentation
  浜松
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Pharmacogenomics of sunitinib in patients with renal cell carcinoma and pharmacokinetic analysis in Abcg2,Abcb1a/1b and triple knockout mice2011
- Author(s)
  Mizuno T, Fukudo M, Terada T, Kamba T, Nakamura E, Ogawa O, Inui K, Katsura T.
- Organizer
  The 112th Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
- Place of Presentation
  Dallas, TX, USA
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] ABCG2遺伝子多型のスニチニブ体内動態に及ぼす影響と遺伝子欠損マウスを用いた薬物動態解析2011
- Author(s)
  水野知行、福土将秀、寺田智祐、神波大己、中村英二郎、小川修、乾賢一、桂敏也
- Organizer
  日本薬学会第131年会
- Place of Presentation
  静岡
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] エルロチニブの母集団薬物動態と副作用に関する薬理ゲノム解析2011
- Author(s)
  福土将秀
- Organizer
  第32回日本臨床薬理学会年会
- Place of Presentation
  アクトシティ浜松（浜松市）
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] 進行肝細胞がん患者におけるソラフェニブの服薬継続並びに有害事象発現に及ぼす影響因子の検討.2011
- Author(s)
  下雅意彩、福土将秀、深津祥央、矢野育子、桂敏也.
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Population pharmacokinetics and pharmacogenomics of erlotinib: Impact of drug exposure on treatment outcomes in Japanese patients with non-small cell lung cancer2011
- Author(s)
  Fukudo M, Ikemi Y, Togashi Y, Masago K, Kim YH, Mio T, Mishima M, Inui K, Katsura T.
- Organizer
  2011 ASCO Annual Meeting
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Investigation of factors influencing treatment continuation with sorafenib and the development of adverse events in patients with advanced hepatocellular carcinoma2011
- Author(s)
  Fukudo M
- Organizer
  第5回若手医療薬科学シンポジウム
- Place of Presentation
  名古屋大学医学部附属病院（名古屋市）
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] 進行肝細胞がん患者におけるソラフェニブの服薬継続並びに有害事象発現に関する要因解析2011
- Author(s)
  福土将秀、下雅意彩、深津祥央、矢野育子、桂敏也
- Organizer
  第5回次世代を担う若手医療薬科学シンポジウム
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23790597
[Presentation] Clinical pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer.2010
- Author(s)
  Fukudo, M.
- Organizer
  日本薬物動態学会第25回年会
- Place of Presentation
  大宮ソニックシティ(埼玉市)
- Year and Date
  2010-10-08
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] 非小細胞肺癌患者におけるエルロチニブの体内動態と副作用に関する母集団解析2010
- Author(s)
  福土将秀
- Organizer
  第31回日本臨床薬理学会年会
- Place of Presentation
  国立京都国際会館(京都市)
- Year and Date
  2010-12-03
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] Upregulation of multidrug resistance-associated protein 4 in the early stage of vascular invasion of hepatocellular carcinoma2010
- Author(s)
  Higuchi K, Terada T, Fukudo M, Ogasawara, K, Katsura T, Hatano E, Ikai I, Inui K.
- Organizer
  2010 ASCO Annual Meeting
- Place of Presentation
  Chicago, IL, USA
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] 非小細胞肺癌患者におけるエルロチニブの体内動態と副作用に関する母集団解析2010
- Author(s)
  福土将秀、池見泰明、寺田智祐、桂敏也、乾賢一、冨樫庸介、真砂勝泰、金永学、三尾直士、三嶋理晃
- Organizer
  第31回日本臨床薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] 質量分析法を用いた経口チロシンキナーゼ阻害薬6種の一斉定量法の確立2010
- Author(s)
  水野知行、増田智先、石橋直哉、福土将秀、矢野育子、乾賢一、桂敏也
- Organizer
  第20回日本医療薬学会年会
- Place of Presentation
  千葉
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] ABCG2遺伝子多型のスニチニブ血中濃度に及ぼす影響2010
- Author(s)
  水野知行、寺田智祐、神波大己、福土将秀、桂敏也、中村英二郎、小川修、乾賢一
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] Clinical pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer2010
- Author(s)
  Fukudo M, Togashi Y, Masago K, Terada T, Katsura T, Kim KH, Mio T, Mishima M, Inui K.
- Organizer
  The 25th JSSX Annual Meeting
- Place of Presentation
  Omiya
- Data Source
  KAKENHI-PROJECT-21790520
[Presentation] Intestinal CYP3A5 genotype and MDR1 expression influence apparent clearance of tacrolimus in adult living-donor liver transplant recipients2007
- Author(s)
  福土将秀
- Organizer
  第10回国際TDM会議
- Place of Presentation
  フランス・ニース市
- Data Source
  KAKENHI-PROJECT-19790387
[Presentation] Intestinal CYP3A5 genotype and MDR1 expression influence apparent clearance of tacrolimus in adult living-donor liver transplant recipients2007
- Author(s)
  Fukudo, M., Yoshimura, A., Yano, I., Masuda, S., Uesugi, M., Hosohata, K., Katsura, T., Takada, Y., Uemoto, S., Inui, K.
- Organizer
  10^<th> International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT2007)
- Place of Presentation
  Nice, France
- Data Source
  KAKENHI-PROJECT-19790387
[Presentation] Intestinal CYP3A5 genotype and MDR1 expression influe nce apparent clearance of tacrolimus in adult living-donor liver transplant recipients2007
- Author(s)
  Fukudo, M, et.al.
- Organizer
  The 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology
- Place of Presentation
  Nice, France
- Data Source
  KAKENHI-PROJECT-19590141
[Presentation] 免疫抑制剤の体内動態と薬効の速度論的解析に基づく個別化投与設計に関する研究2007
- Author(s)
  福土将秀, 他
- Organizer
  第57回日本薬学会近畿支部総会・大会
- Place of Presentation
  大阪
- Year and Date
  2007-10-27
- Data Source
  KAKENHI-PROJECT-19590141
[Presentation] Cyclooxygenase (COX) 阻害作用を持たないmeloxicam類縁体もMPP+誘発SH-SY5Y神経細胞死を抑制する
- Author(s)
  坂口智己，小野尚志，海東和麻，山本譲，神山直也，高橋恭子，粟屋敏雄，福土将秀，大江知之，増野匡彦，田﨑嘉一
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸
- Year and Date
  2015-03-25 – 2015-03-28
- Data Source
  KAKENHI-PROJECT-25460204

1. YANO Ikuko (50273446)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
2. IKEDA Akio (90212761)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. MASUDA Satohiro (90303825)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
4. TERADA Tomohiro (10324641)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
5. YANAGIHARA Kazuhiro (70332731)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. HATANO Etsuro (80359801)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. UENO Takayuki (40452362)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. KAMBA Tomomi (20402836)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. TERAMUKAI Satoshi (20359798)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. MATSUBARA Kazuo (20127533)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. YONEZAWA Atsushi (90452341)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. OMURA Tomohiro (00439035)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. NAKAGAWA Shunsaku (50721916)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. TASAKI YOSHIKAZU (60374807)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. Kamiyama Naoya (20431398)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
16. 寺田智祐 (10364241)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. KURONUMA Koji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 安藤勝祥

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
19. 桂敏也

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. 小船雅義

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 池田博

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 神波大己

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
23. 水上裕輔

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Fukudo Masahide 福土 将秀

FUKUDO Masahide 福土 将秀

Research Projects

Research Products

Co-Researchers

免疫チェックポイント阻害薬のPK/PD解析と抗薬物抗体評価に基づく最適使用法開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Personalized dosing of targeted anticancer drugs by elucidating mechanisms underlying the variability in pharmacokinetics and pharmacodynamicsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the antiparkinsonian drug with novel mechanism by drug-reprofiling.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Individualized L-dopa therapy in patients with Parkinson's disease

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Individualized molecular targeted therapy based on pharmacogenomics and pharmacokinetic optimizationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Construction of administration algorithm of novel oral molecular-targeted anti-cancer drugs based on the clarificationof interindividual differences of pharmacokinetics and pharmacodynamics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Population pharmacokinetics and pharmacodynamics and individualized therapy in patients with refractory epilepsy

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of personalized chemotherapy with novel molecular targeted agents based on pharmacokinetic and pharmacogenomic analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Dosage schedule based on pharmacokinetic and pharmacodynamic interaction of immunosuppressants

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Optimal mycophenolate therapy based on population pharmacokinetic and pharmacodynamic analysis in liver transplant patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pharmacokinetics of the oral multikinase inhibitor regorafenib and its association with real‐world treatment outcomes2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential drug?drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan2021

Author(s)

Journal Title

DOI

Data Source

Fukudo Masahide 福土将秀

FUKUDO Masahide 福土将秀